Sign In
24 Jun 2015 09:33
Annex DTR3
Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons
All relevant boxes should be completed in block capital letters.
1. | Name of the issuer
Consort Medical plc | 2. | State whether the notification relates to (i) a transaction notified in accordance with DTR 3.1.2 R, (ii) a disclosure made in accordance LR 9.8.6R(1) or (iii) a disclosure made in accordance with section 793 of the Companies Act (2006).
I - DTR 3.1.2 |
3. | Name of person discharging managerial responsibilities/director
Jon Glenn Richard Cotton
| 4. | State whether notification relates to a person connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person
N/A |
5. | Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a nonbeneficial interest 1
The Notification is in respect of the Holdings of the persons referred to in 3 above.
| 6. | Description of shares (including class), debentures or derivatives or financial instruments relating to shares
N/A
|
7. | Name of registered shareholders(s) and, if more than one, the number of shares held by each of them
N/A
| 8. | State the nature of the transaction
N/A |
9. | Number of shares, debentures or financial instruments relating to shares acquired
N/A | 10. | Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)
N/A
|
11. | Number of shares, debentures or financial instruments relating to shares disposed
N/A | 12. | Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage) N/A
|
| |||
13. | Price per share or value of transaction
N/A
| 14. | Date and place of transaction
N/A
|
15. | Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)
N/A
| 16. | Date issuer informed of transaction
N/A
|
If a person discharging managerial responsibilities has been granted options by the issuer
complete the following boxes
17. | Date of grant
19 June 2015 | 18. | Period during which or date on which exercisable
June 2018 to July 2018 provided the applicable performance criteria have been satisfied.
| |||||||||
19. | Total amount paid (if any) for grant of the option
NIL | 20. | Description of shares or debentures involved (class and number)
Grant of Performance Shares under the Consort Medical 2005 Long Term Incentive Plan in respect of ordinary 10 pence shares as indicated in the table below: | |||||||||
| ||||||||||||
21. | Exercise price (if fixed at time of grant) or indication that price is to be fixed at the time of exercise
| 22. | Total number of shares or debentures over which options held following notification including Deferred Bonus Awards
Please see table below: | |||||||||
| ||||||||||||
23. | Any additional information
None | 24. | Name of contact and telephone number for queries
Iain Ward- 01442 867920 | |||||||||
Name of authorised official of issuer responsible for making notification - John Slater
Date of notification: 24 June 2015
|
Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.
(1) | An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. |
(2) | An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. |
(3) | An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24. |
(4) | An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. |
Follow the stocks
